Test Price
2,800 AEDโ Home Collection Available
MOCS2 Gene Molybdenum Cofactor Deficiency Type B Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Clinical Information at a Glance
- 99.9% Diagnostic Sensitivity โ ISO 9001:2015 Accredited Next-Generation Sequencing (NGS) Processing
- Hospital-Grade Home Collection โ Temperature-Controlled Cold-Chain VIP Mobile Phlebotomy (8 AM โ 11 PM)
- Telephonic Post-Test Clinical Guidance โ Expert interpretation of your molecular results by a Consultant Medical Geneticist
- Direct Insurance Billing Verification โ Instant WhatsApp confirmation at +971 54 548 8731
Corporate Oversight: DNA Labs UAE | Consultant Medical Geneticist: Lina Osama Zaki Quteineh (DHA Registration ID: 9294403)
Test Overview & Methodology
This diagnostic assay employs advanced Next-Generation Sequencing (NGS) to detect pathogenic variants in the MOCS2 gene. Molybdenum Cofactor Deficiency Type B is a severe autosomal recessive neurometabolic disorder characterized by intractable seizures, feeding difficulties, and rapid neurodegeneration in infancy. Definitive molecular confirmation via NGS is essential for accurate prognosis, carrier detection, and family planning.
| Feature | Our MOCS2 NGS Test | Alternative Methodology (Biochemical) |
|---|---|---|
| Methodology | Full-gene NGS with CNV detection | Urine sulfite / S-sulfocysteine quantification |
| Diagnostic Precision | >99.9% for single nucleotide variants, indels | Indirect screening; may miss late-onset or partial deficiencies |
| Turnaround Time | 3 โ 4 weeks | 1 โ 2 weeks |
| Clinical Utility | Confirms diagnosis, carrier testing, prenatal options | Screening only; genetic confirmation remains mandatory |
Physician Insight & Safety Protocols
โAs a consultant medical geneticist analyzing rare neurometabolic pathways, I cannot overstate the importance of definitive molecular confirmation in Molybdenum Cofactor Deficiency Type B. This NGS assay provides the precise genotypic resolution required for accurate family counselling and clinical management. Our team ensures rigorous pre-test and post-test counselling to support families throughout the diagnostic journey.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory & Clinical Exclusion Criteria
- Clinical Advisory: This test must not be interpreted as a standalone diagnostic entity without correlation to clinical phenotype and biochemical markers. Immediate medical attention for seizures or respiratory distress supersedes all genetic testing protocols.
- Exclusion: Testing for minors requires documented consent from both parents or legal guardians in full compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability. This assay is not a substitute for newborn metabolic screening.
Patient FAQ & Clinical Guidance
1. What is MOCS2 gene molybdenum cofactor deficiency type B?
Snippet: Molybdenum Cofactor Deficiency Type B is an exceptionally rare genetic disorder causing severe neurological impairment from birth due to the buildup of toxic metabolites.
This autosomal recessive condition results from mutations in the MOCS2 gene, disrupting molybdenum cofactor biosynthesis. Deficiency of this cofactor inactivates sulfite oxidase and xanthine dehydrogenase, leading to intractable seizures, feeding problems, and progressive neurodegeneration. Our NGS assay identifies the precise DNA variant for definitive diagnosis and genetic counselling.
2. How is the sample collected, and what does the 3โ4 week turnaround time mean?
Snippet: A peripheral blood draw, extracted DNA, or an FTA card sample is collected via our certified mobile phlebotomy service and analyzed using high-throughput NGS.
Our skilled phlebotomist arrives at your home with a temperature-controlled cold-chain transport kit. The sample undergoes library preparation, Illuminaยฎ sequencing, and comprehensive bioinformatic analysis. The 3โ4 week turnaround time includes rigorous validation steps and detailed clinical report generation by our board-certified molecular genetics team.
3. Is home collection available and covered by insurance?
Snippet: Yes, ISO-certified VIP mobile phlebotomy is operational across the UAE daily from 8 AM to 11 PM, with instant insurance verification via WhatsApp.
All sample handling complies with UAE data privacy regulations. To confirm your policy benefits, send a photo of your insurance card to +971 54 548 8731. Our team responds within minutes with a detailed coverage statement. Self-pay patients receive an all-inclusive invoice for 2800 AED.
UAE Regulatory & Data Privacy Adherence
Trust & Compliance Framework
Your health information and genetic data are protected under the United Arab Emirates strict regulatory ecosystem. DNA Labs UAE operates in full compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) โ Governing the collection, processing, and storage of your personal genomic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields โ Ensuring secure management of digital health records and telemedicine frameworks.
- Federal Decree-Law No. 4 of 2016 on Medical Liability โ Upholding patient rights and clinical safety standards for diagnostic procedures.
ISO 9001:2015 Certified (INT/EGQ/2509DA/3139) | DHA Facility License: 1143
Clinical & Logistical Metadata
| Test Name | MOCS2 Gene Molybdenum Cofactor Deficiency Type B Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 โ 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV Detection |
| ICD-10-CM Code | E83.1 |
| LOINC Code | 52297-8 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians